A novel immunocompetent murine model for Candida albicans-promoted oral epithelial dysplasia

Medical Mycology

Volumn 47, Issue 2, 2009, Pages 157-167

  Dwivedi, P P ^a   Mallya, S ^a   Dongari Bagtzoglou, A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

4NQO; Candida albicans; Murine model; Oral epithelial dysplasia

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; DIMETHYL SULFONE; KI 67 ANTIGEN; PROTEIN P16;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CANCER GROWTH; CANCER INFILTRATION; CANDIDA ALBICANS; CARCINOGENESIS; CELL CYCLE REGULATION; CELL INVASION; CELL MATURATION; CONTROLLED STUDY; EPITHELIUM CELL; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; MOUTH CARCINOMA; MOUTH MUCOSA; MYCOSIS; NONHUMAN;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CARCINOGENS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOCOMPETENCE; MICE; MICE, INBRED C57BL; MOUTH MUCOSA; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS;

CANDIDA; CANDIDA ALBICANS; MURINAE; MUS;

EID: 59249083174     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802165797     Document Type: Article

References (68)

1. Arendorf, TM and Walker, DM. (1979) Oral candidal populations in health and disease. Br Dent J, 147, pp. 267-272.
2. Walsh, TJ and Merz, WG. (1986) Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis. Am J Clin Pathol, 85, pp. 498-502.
3. Saltarelli, CG, Gentile, KA and Mancuso, SC. (1975) Lethality of Candida strains as influenced by the host. Can J Microbiol, 21, pp. 648-654.
4. Arendorf, TM and Walker, DM. (1980) The prevalence and Intraoral distribution of Candida albicans in man. Arch Oral Biol, 2, pp. 507-538.
5. Samaranayake, LP. (1992) Oral mycoses in HIV infection. Oral Surg Oral Med Oral Pathol, 73, pp. 171-180.
6. Cumming, CL, White, C., Blackwell, CL and Wray, D. (1990) Denture stomatitis in the elderly. Oral Microbiol Immunol, 5, pp. 82-85.
7. Taschdjian, CL, Seelig, MS and Kozinn, PJ. (1973) Serological diagnosis of candidal infections. CRC Crit Rev Clin Lab Sci, 4, pp. 19-59.
8. Heimdahl, A. and Nord, CE. (1990) Oral yeast infections in immunocompromised and seriously diseased patients. Acta Odontol Scand, 48, pp. 77-84.
9. Horn, R., Wong, B., Kiehn, TE and Armstrong, D. (1985) Fungemia in a cancer hospital: Changing frequency, earlier onset, and results of therapy. Rev Infect Dis, 7, pp. 646-655.
10. Wingard, JR, Merz, WG Rinaldi, MG et al. (1991) Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med, 325, pp. 1274-1277.
11. Bodey, GP. (1986) Fungal infection and fever of unknown origin in neutropenic patients. Am J Med, 80, pp. 112-119.
12. Gold, JW. (1984) Opportunistic fungal infections in patients with neoplastic disease. Am J Med, 76, pp. 458-463.
13. Maksymiuk, AW, Thongprasert, S. Hopfer, R. et al. (1984) Systemic candidiasis in cancer patients. Am J Med, 77, pp. 20-27.
14. Tang, XN, Knudsen, B., Bemis, D., Tickoo, S. and Gudas, LJ. (2004) Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin Can Res, 10, pp. 301-313.
15. Cawson, RA. (1969) Leukoplakia and oral cancer. Proc R Soc Med, 62, pp. 610-614.
16. Nagy, KN, Sonkodi, I., Szoke, I., Nagy, E. and Newman, HN. (1998) The microflora associated with human oral carcinomas. Oral Oncol, 34, pp. 304-308.
17. Roed-Petersen, B., Renstrup, G. and Pindborg, JJ. (1970) Candida in oral leukoplakias. A histologic and exfoliative cytologic study. Scand J Dent Res, 78, pp. 323-328.
18. Renstrup, G. (1970) Occurrence of Candida in oral leukoplakias. Acta Pathol Microbiol Scand [B] Microbiol Immunol, 78, pp. 421-424.
19. Daftary, DK, Mehta, FS, Gupta, PC and Pindborg, JJ. (1972) The presence of Candida in 723 oral leukoplakias among Indian villagers. Scand J Dent Res, 80, pp. 75-79.
20. McCullough, M., Jaber, M. Barrett, AW et al. (2002) Oral yeast carriage correlates with presence of oral epithelial dysplasia. Oral Oncol, 38, pp. 391-393.
21. (1986) 38, International Agency for Research on Cancer, Lyons, France
22. (1988) 44, International Agency for Research on Cancer, Lyons, France
23. Blot, WJ. (1999) Invited commentary: More evidence of increased risks of cancer among alcohol drinkers. Am J Epidemiol, 150, pp. 1138-1140.
24. Phillips, DH. (2002) Smoking-related DNA and protein adducts in human tissues. Carcinogenesis, 23, pp. 1979-2004.
25. Panigrahi, GB and Walker, IG. (1990) The N2-guanine adduct but not the C8-guanine or N6-adenine adducts formed by 4-nitroquinoline 1-oxide blocks the 3'-5' exonuclease action of T4 DNA polymerase. Biochemistry, 29, pp. 2122-2126.
26. Thomas, DC, Husain, I., Chaney, SG, Panigrahi, GB and Walker, IG. (1991) Sequence effect on incision by (A)BC excinuclease of 4NQO adducts and UV photoproducts. Nucleic Acids Res, 19, pp. 365-370.
27. Venkat, JA, Shami, S. Davis, K. et al. (1995) Relative genotoxic activities of pesticides evaluated by a modified SOS microplate assay. Environ Mol Mutagen, 25, pp. 67-76.
28. Tanuma, J., Shisa, H. Hiai, H. et al. (1998) Quantitative trait loci affecting 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in the rat. Cancer Res, 58, pp. 1660-1664.
29. O'Grady, JF and Reade, PC. (1992) Candida albicans as a promoter of oral mucosal neoplasia. Carcinogenesis., 13, pp. 783-786.
30. Hawkins, BL, Heniford, BW Ackermann, DM et al. (1994) 4NQO carcinogenesis: A mouse model of oral cavity squamous cell carcinoma. Head Neck, 16, pp. 424-432.
31. Steidler, NE and Reade, PC. (1984) Experimental induction of oral squamous cell carcinomas in mice with 4-nitroquinolone-1-oxide. Oral Surg Oral Med Oral Pathol, 57, pp. 524-531.
32. Yuan, B., Heniford, BW, Ackermann, DM, Hawkins, BL and Hendler, FJ. (1994) Harvey ras (H-ras) point mutations are induced by 4-nitroquinoline-1-oxide in murine oral squamous epithelia, while squamous cell carcinomas and loss of heterozygosity occur without additional exposure. Cancer Res, 54, pp. 5310-5317.
33. de Repentigny, L. (2004) Animal models in the analysis of Candida host-pathogen interactions. Curr Opin Microbiol, 7, pp. 324-329.
34. Cantorna, MT and Balish, E. (1990) Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect Immun, 58, pp. 1093-1100.
35. Sundstrom, P., Balish, E. and Allen, CM. (2002) Essential role of the Candida albicans transglutaminase substrate, hyphal wall protein 1, in lethal oroesophageal candidiasis in immunodeficient mice. J Infect Dis, 185, pp. 521-530.
36. Deslauriers, N., Coulombe, C., Carre, B. and Goulet, JP. (1995) Topical application of a corticosteroid destabilizes the host-parasite relationship in an experimental model of the oral carrier state of Candida albicans. FEMS Immunol Med Microbiol, 11, pp. 45-56.
37. Balish, E., Balish, MJ, Salkowski, CA, Lee, KW and Bartizal, KF. (1984) Colonization of congenitally athymic, gnotobiotic mice by Candida albicans. Appl Environ Microbiol, 47, pp. 647-652.
38. Rahman, D., Mistry, M., Thavaraj, S., Challacombe, S. and Naglik, J. (2007) Murine model of concurrent oral and vaginal Candida albicans colonization to study epithelial host-pathogen interactions. Microbes Infect, 9, pp. 615-622.
39. Turner, JR, Butler, TF, Johnson, ME and Gordee, RS. (1976) Colonization of the intestinal tract of conventional mice with Candida albicans and treatment with antifungal agents. Antimicrob Agents Chemother, 9, pp. 787-792.
40. Ide, F., Oda, H. Nakatsuru, Y. et al. (2001) Xeroderma pigmentosum group A gene action as a protection factor against 4-nitroquinoline 1-oxide-induced tongue carcinogenesis. Carcinogenesis, 22, pp. 567-572.
41. Schlfiter, C., Duchrow, M. Wohlenberg, C. et al. (1993) The cell proliferation-associated antigen of antibody Ki-67: A very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol, 123, pp. 513-522.
42. Goodger, NM, Gannon, J., Hunt, T. and Morgan, PR. (1997) Cell cycle regulatory proteins - an overview with relevance to oral cancer. Oral Oncol, 33, pp. 61-73.
43. Jones, JH, Russell, C., Young, C. and Owen, D. (1976) Tetracycline and the colonization and infection of the mouths of germ-free and conventionalized rats with Candida albicans. J Antimicrob Chemother, 2, pp. 247-253.
44. Kamai, Y., Kubota, M. Kamai, Y. et al. (2001) New model of oropharyngeal candidiasis in mice. Antimicrob Agents Chemother, 45, pp. 3195-3197.
45. Clemons, KV, Gonzalez, GM Singh, G. et al. (2006) Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs. Antimicrob Agents Chemother, 50, pp. 2650-2657.
46. Bouquot, JE, Speight, PM and Farthing, PM. (2006) Epithelial dysplasia of the oral mucosa-Diagnostic problems and prognostic fatures. Current Diagnostic Pathology, 12, pp. 11-21.
47. Vairaktaris, E., Spyridonidou, S. Papakosta, V. et al. (2008) The hamster model of sequential oral oncogenesis. Oral Oncol, 44, pp. 315-324.
48. Louis, DR, Martine, P. and Leo-Gilles, M. (1992) Gastrointestinal clonization and systemic dissemination by Candida albicans and Candida tropicalis in intact and immunocompromised mice. Infect Immun, 60, pp. 4907-4914.
49. Steidler, NE and Reade, PC. (1986) Initiation and promotion of experimental oral mucosal carcinogenesis in mice. J Oral Pathol, 15, pp. 43-47.
50. Marilena, V., Noam, Y. and Dan, D. (2005) 4NQO oral carcinogenesis: animal models, molecular markers and future expectations. Oral Oncol, 41, pp. 337-339.
51. Allen, CM, Saffer, A., Meister, RK, Beck, FM and Bradway, S. (1994) Comparison of a lesion-inducing isolate and a non-lesional isolate of Candida albicans in an immunosuppressed rat model of oral candidiasis. J Oral Pathol Med, 23, pp. 133-139.
52. Balish, E., Filutowixz, J. and Oberley, TD. (1990) Correlates of cell-mediated immunity in C. albicans colonized gnotobiotic mice. Infect Immun, 58, pp. 107-113.
53. Deslauriers, N., Cote, L., Montplaisir, S. and de Repentigny, L. (1997) Oral carriage of Candida albicans in murine AIDS. Infect Immun, 65, pp. 661-667.
54. Krogh, P., Holmstrup, P., Thorn, JJ, Vedtofte, P. and Pindborg, JJ. (1987) Yeast species and biotypes associated with oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol, 63, pp. 48-54.
55. Bunetel, L. and Bonnaure-Mallet, M. (1996) Oral pathoses caused by Candida albicans during chemotherapy: Update on development mechanisms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 82, pp. 161-165.
56. Nseir, S., Jozefowicz, E. Cavestri, B. et al. (2007) Impact of antifungal treatment on Candida-Pseudomonas interaction: A preliminary retrospective case-control study. Intensive Care Med, 33, pp. 137-142.
57. Hogan, DA and Kolter, R. (2002) Pseudomonas-Candida interactions: An ecological role for virulence factors. Science, 296, pp. 2229-2232.
58. Thein, ZM, Samaranayake, YH and Samaranayake, LP. (2006) Effect of oral bacteria on growth and survival of Candida albicans biofilms. Arch Oral Biol, 51, pp. 672-680.
59. Farrelly, JG, Stewart, ML, Saavedra, JE and Lijinsky, W. (1982) Relationship between carcinogenicity and in vitro metabolism of nitrosomethylethylamine, nitrosomethyl-N-butylamine, and nitrosomethyl-(2-phenylethyl)amine labeled with duterium in the mthyl and α-mthylene positions. Cancer Res, 42, pp. 2105-2109.
60. Jordan, RC, Bradley, G. and Slingerland, J. (1998) Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity. Am J Pathol, 152, pp. 585-590.
61. Radovic, S., Vukobrat-Bijedic, Z., Selak, I. and Babic, M. (2006) Expression of p53, bcl-2, and Ki-67 proteins in the inflammatory regenerative and dysplastic epithelial lesions of flat colonic mucosa. Bosn J Basic Med Sci, 6, pp. 39-45.
62. Zhao, J., Guo, B., Ma, SC and Zhou, XD. (2005) Expression of p53 and Ki-67 genes in epithelial dysplasia from old oral mucosa and clinical significance. Sichuan Da Xue Xue Bao Yi Xue Ban, 36, pp. 689-691.
63. Kamb, A., Gruis, NA Weaver-Feldhaus, J. et al. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, pp. 436-440.
64. Serrano, M., Hannon, GJ and Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366, pp. 704-707.
65. Yeudall, WA and Jakus, J. (1995) Cyclin kinase inhibitors add a new dimension to cell cycle control. Eur J Cancer B Oral Oncol, 31, pp. 291-298.
66. Sugerman, PB, Joseph, BK and Savage, NW. (1995) The role of oncogenes, tumour suppressor genes and growth factors in oral squamous cell carcinoma: A case of apoptosis versus proliferation. Oral Dis, 1, pp. 172-188.
67. Klaes, R., Friedrich, T. Spitkovsky, D. et al. (2001) Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer, 92, pp. 276-284.
68. Cunningham Jr, LL, Pagano, GM Li, M. et al. (2006) Overexpression of p16INK4 is a reliable marker of human papillomavirus-induced oral high-grade squamous dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 102, pp. 77-81.